NRX Pharmaceuticals Inc (NASDAQ:NRXP) has a beta value of 1.08 and has seen 4.1 million shares traded in the last trading session. The company, currently valued at $38.19M, closed the last trade at $3.51 per share which meant it gained $0.82 on the day or 30.48% during that session. The NRXP stock price is -108.83% off its 52-week high price of $7.33 and 68.66% above the 52-week low of $1.10. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.36 million shares traded. The 3-month trading volume is 707.77K shares.
The consensus among analysts is that NRX Pharmaceuticals Inc (NRXP) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
NRX Pharmaceuticals Inc (NASDAQ:NRXP) trade information
Sporting 30.48% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the NRXP stock price touched $3.51 or saw a rise of 7.63%. Year-to-date, NRX Pharmaceuticals Inc shares have moved 59.55%, while the 5-day performance has seen it change 132.45%. Over the past 30 days, the shares of NRX Pharmaceuticals Inc (NASDAQ:NRXP) have changed 187.70%. Short interest in the company has seen 0.68 million shares shorted with days to cover at 4.8.
Wall Street analysts have a consensus price target for the stock at $2, which means that the shares’ value could drop -75.5% from current levels. The projected low price target is $2.0 while the price target rests at a high of $2.0. In that case, then, we find that the current price level is 43.02% off the targeted high while a plunge would see the stock lose 43.02% from current levels.
NRX Pharmaceuticals Inc (NRXP) estimates and forecasts
Figures show that NRX Pharmaceuticals Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 51.29% over the past 6 months, with this year growth rate of 52.70%, compared to 16.60% for the industry.
NRXP Dividends
NRX Pharmaceuticals Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
NRX Pharmaceuticals Inc (NASDAQ:NRXP)’s Major holders
Insiders own 23.56% of the company shares, while shares held by institutions stand at 6.05% with a share float percentage of 7.92%. Investors are also buoyed by the number of investors in a company, with NRX Pharmaceuticals Inc having a total of 21.0 institutions that hold shares in the company.
